https://pubmed.ncbi.nlm.nih.gov/34470049/
Proteins in the antiapoptotic B-cell lymphoma 2 (BCL-2) family play a role in the pathophysiology of multiple myeloma (MM). Venetoclax is a highly selective,...
phasestudyvenetoclaxpluscarfilzomib
https://www.ajmc.com/view/patients-with-rrmm-are-undertreated-with-carfilzomib-in-the-real-world-study-finds
Since carfilzomib was approved at a 27 mg/m2 twice-weekly dose, it has since been optimized at 56 mg/m2 twice-weekly and a recent study found benefits of a 70...
in thepatientsrrmmcarfilzomibreal